Dr. Gurbuxani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200Fax+1 773-702-1200
Education & Training
- University of ChicagoFellowship, Hematopathology, 2007 - 2008
- University of ChicagoResidency, Pathology-Anatomic and Clinical, 2004 - 2007
- Moti Lal Nehru Medical CollegeClass of 1992
Certifications & Licensure
- IL State Medical License 2006 - 2026
- IN State Medical License 2020 - 2025
- American Board of Pathology Pathology - Clinical
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- Microbiota does not influence tumor development in two models of heritable cancer.Jessica Spring, Sandeep Gurbuxani, Tatyana Golovkina
Mbio. 2025-02-19 - Diagnosis and treatment of AML in the context of WHO and ICC 2022 classifications: Divergent nomenclature converges on common therapies.Uwe Platzbecker, Richard A Larson, Sandeep Gurbuxani
Hemasphere. 2025-02-01 - CD58 expression does not impact response to inotuzumab ozogamicin in patients with B-cell acute lymphoblastic leukemia.Rafael Madero-Marroquin, Ryan W Hunter, Caner Saygin, Hannah Johnston, Adam S DuVall
Ejhaem. 2025-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: